Brief: Cellavision AB Says Co To Acquire RAL Diagnostics

CellaVision AB

16/09/2019 17:40

Sept 16 (Reuters) - CellaVision AB  CEVI.ST :
    * CELLAVISION AB TO ACQUIRE RAL DIAGNOSTICS
    * CASH PURCHASE PRICE IS SEK 268 MLN ON A CASH AND DEBT-FREE
BASIS
    * DEAL FINANCED THROUGH COMBINATION OF CO'S OWN CASH & CASH
EQUIVALENTS, BANK LOANS ARRANGED BY SKANDINAVISKA ENSKILDA
BANKEN OF SEK 120 MLN
    * THROUGH ACQUISITION CELLAVISION'S SALES IN EMEA WILL GROW
BY
MORE THAN 90 PERCENT AND GLOBALLY BY ABOUT 25 PERCENT 
    * CELLAVISION'S ORGANIC GROWTH TARGET OF 15 PERCENT AND AN
EBIT
MARGIN OF 20 PERCENT REMAIN UNCHANGED 
    * ACQUISITION IS EXPECTED TO INCREASE CELLAVISION'S
ADDRESSABLE TO
A TOTAL MARKET VALUE OF SEK 6 BLN

Source text for Eikon:  ID:nGNE4J2fvF 
Further company coverage:  CEVI.ST 

 ((Reuters.Briefs@thomsonreuters.com;))